Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 22 | 2024 | 3038 | 2.670 |
Why?
|
Pulmonary Emphysema | 5 | 2024 | 672 | 1.490 |
Why?
|
Eosinophils | 2 | 2018 | 953 | 0.910 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2023 | 451 | 0.900 |
Why?
|
Lung | 12 | 2023 | 9826 | 0.730 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.670 |
Why?
|
Respiration Disorders | 1 | 2022 | 370 | 0.660 |
Why?
|
Forced Expiratory Volume | 3 | 2022 | 1741 | 0.660 |
Why?
|
Lymphocytes | 1 | 2021 | 2614 | 0.450 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3769 | 0.430 |
Why?
|
Emphysema | 4 | 2024 | 247 | 0.390 |
Why?
|
Carrier Proteins | 2 | 2021 | 5019 | 0.370 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9410 | 0.340 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2007 | 56 | 0.300 |
Why?
|
RNA Viruses | 1 | 2008 | 124 | 0.300 |
Why?
|
Gene Expression Regulation | 3 | 2022 | 12071 | 0.280 |
Why?
|
Leukocyte Count | 3 | 2018 | 1583 | 0.270 |
Why?
|
Vitamin B Complex | 1 | 2007 | 288 | 0.260 |
Why?
|
BCG Vaccine | 1 | 2007 | 367 | 0.250 |
Why?
|
Tobacco Smoke Pollution | 2 | 2021 | 814 | 0.240 |
Why?
|
Vitamin A | 1 | 2007 | 615 | 0.240 |
Why?
|
Smoking | 4 | 2021 | 8969 | 0.240 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 186 | 0.220 |
Why?
|
Inflammation | 2 | 2023 | 10578 | 0.220 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 164 | 0.200 |
Why?
|
Desmoplakins | 1 | 2020 | 62 | 0.190 |
Why?
|
Folic Acid | 1 | 2007 | 1300 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4438 | 0.180 |
Why?
|
Vitamins | 1 | 2007 | 1608 | 0.170 |
Why?
|
Interferons | 1 | 2022 | 704 | 0.160 |
Why?
|
Genome-Wide Association Study | 4 | 2021 | 12220 | 0.160 |
Why?
|
Disease Progression | 5 | 2023 | 13256 | 0.160 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 497 | 0.160 |
Why?
|
F-Box Proteins | 1 | 2019 | 197 | 0.150 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 468 | 0.150 |
Why?
|
Xenobiotics | 1 | 2017 | 73 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3502 | 0.150 |
Why?
|
Genotype | 2 | 2022 | 12946 | 0.150 |
Why?
|
Phenotype | 5 | 2022 | 16331 | 0.140 |
Why?
|
Adenoma | 1 | 2007 | 2168 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 569 | 0.140 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2011 | 0.140 |
Why?
|
Heterozygote | 1 | 2022 | 2790 | 0.130 |
Why?
|
Exons | 2 | 2019 | 2431 | 0.130 |
Why?
|
Spirometry | 1 | 2018 | 862 | 0.130 |
Why?
|
RNA | 2 | 2023 | 2747 | 0.120 |
Why?
|
Signal Transduction | 2 | 2017 | 23387 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2016 | 329 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17400 | 0.120 |
Why?
|
Alternative Splicing | 1 | 2019 | 1118 | 0.120 |
Why?
|
RNA, Untranslated | 1 | 2017 | 454 | 0.120 |
Why?
|
Gene Expression | 3 | 2021 | 7790 | 0.110 |
Why?
|
Adaptive Immunity | 1 | 2018 | 712 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18006 | 0.110 |
Why?
|
Respiratory Function Tests | 3 | 2022 | 1613 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1582 | 0.110 |
Why?
|
Humans | 32 | 2024 | 742088 | 0.110 |
Why?
|
Mice, Knockout | 3 | 2021 | 14554 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2018 | 2956 | 0.100 |
Why?
|
Fibroblasts | 1 | 2021 | 4143 | 0.100 |
Why?
|
Venous Thromboembolism | 2 | 2014 | 1668 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21821 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2039 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2013 | 453 | 0.090 |
Why?
|
Endocarditis | 1 | 2013 | 348 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 759 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3081 | 0.080 |
Why?
|
Oxygen | 2 | 2018 | 4169 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3563 | 0.080 |
Why?
|
Gambia | 1 | 2007 | 98 | 0.080 |
Why?
|
Aged | 12 | 2022 | 162944 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2699 | 0.080 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6754 | 0.080 |
Why?
|
Sepsis | 1 | 2021 | 2589 | 0.070 |
Why?
|
Animals | 9 | 2023 | 168561 | 0.070 |
Why?
|
Asthma | 2 | 2021 | 5955 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 363 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1517 | 0.070 |
Why?
|
Models, Genetic | 1 | 2017 | 3493 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1272 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13921 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9144 | 0.070 |
Why?
|
Mice | 6 | 2023 | 81045 | 0.070 |
Why?
|
Male | 16 | 2022 | 349538 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 19223 | 0.070 |
Why?
|
Middle Aged | 11 | 2022 | 213127 | 0.070 |
Why?
|
Genetic Variation | 1 | 2020 | 6540 | 0.060 |
Why?
|
Morphogenesis | 1 | 2008 | 752 | 0.060 |
Why?
|
Female | 15 | 2022 | 379592 | 0.060 |
Why?
|
Drug Interactions | 1 | 2007 | 1458 | 0.050 |
Why?
|
Virus Diseases | 1 | 2008 | 710 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6440 | 0.050 |
Why?
|
Hypertension, Pulmonary | 2 | 2008 | 1527 | 0.050 |
Why?
|
Proteomics | 2 | 2024 | 3618 | 0.050 |
Why?
|
Atherosclerosis | 2 | 2014 | 3428 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23320 | 0.050 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 28 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57683 | 0.040 |
Why?
|
Aspirin | 2 | 2011 | 3278 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 29717 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11690 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 21596 | 0.040 |
Why?
|
Sex Factors | 2 | 2013 | 10392 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1040 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2276 | 0.040 |
Why?
|
Lung Diseases | 1 | 2007 | 1884 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1342 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 16678 | 0.040 |
Why?
|
Glutathione S-Transferase pi | 1 | 2016 | 97 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3239 | 0.030 |
Why?
|
Lung Compliance | 1 | 2016 | 191 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 670 | 0.030 |
Why?
|
Hepacivirus | 1 | 2023 | 1372 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2008 | 3455 | 0.030 |
Why?
|
Genetic Markers | 1 | 2022 | 2633 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9679 | 0.030 |
Why?
|
Acetylcysteine | 1 | 2016 | 272 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2524 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1190 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2899 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15056 | 0.030 |
Why?
|
Glutathione | 1 | 2016 | 586 | 0.030 |
Why?
|
Philadelphia | 1 | 2013 | 263 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2713 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15530 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9581 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2015 | 0.020 |
Why?
|
Risk Factors | 3 | 2022 | 72145 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2007 | 25575 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9846 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10248 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3678 | 0.020 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 222 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18355 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53187 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2007 | 198 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2011 | 1007 | 0.020 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2007 | 214 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2007 | 381 | 0.020 |
Why?
|
Ticlopidine | 1 | 2011 | 899 | 0.020 |
Why?
|
Infant | 1 | 2007 | 35070 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2007 | 739 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1123 | 0.020 |
Why?
|
Incidence | 2 | 2013 | 20928 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2022 | 21719 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2749 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5692 | 0.010 |
Why?
|
Telomere | 1 | 2008 | 909 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12164 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6483 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6534 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2008 | 2211 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39004 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5310 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15494 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2014 | 3258 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 3067 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2370 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12344 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40054 | 0.010 |
Why?
|
Adult | 2 | 2022 | 213712 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 77098 | 0.010 |
Why?
|
Stroke | 1 | 2014 | 9963 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 24913 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 40450 | 0.010 |
Why?
|
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_